Chicago TPP Stakeholder Forum, 9/10/11. Photo from ustr.gov

Last week the U.S. tabled additional text on intellectual property at the Trans Pacific Partnership negotiating round in Chicago. The text is confidential, but trade officials told reporters that it includes TRIPS-Plus measures affecting access to medicines such as”stronger patent linkage, patent term extension and data exclusivity provisions.”  The inclusion of these provisions amounts to a retreat from the 2007 “May 10” trade policy meant to protect access to generic medicines in developing countries.

USTR released a white paper on trade and access to medicines, which did not describe in detail the American proposals on IP. It does indicate that TRIPS-Plus IP protection will be conditional on the entry of new products into foreign markets within a “window” of time.

The negotiating round included a stakeholder forum where negotiators heard from civil society groups.

USTR White Paper on Access to Medicines

Presentations at Chicago Negotiating Round Stakeholder Forum

Blogs from the Chicago Negotiating Round

Letters from Members of Congress to Obama Administration